Y. Takahashi et al., SOLUBLE THROMBOMODULIN PURIFIED FROM HUMAN URINE EXHIBITS A POTENT ANTICOAGULANT EFFECT IN-VITRO AND IN-VIVO, Thrombosis and haemostasis, 73(5), 1995, pp. 805-811
We examined the anticoagulant activity of two major molecules of solub
le thrombomodulin purified from human urine. The apparent molecular we
ights of these urinary thrombomodulins (UTMs) were 72,000 and 79,000,
respectively. Both UTMs showed more potent cofactor activity for prote
in C activation [specific activity > 5,000 thrombomodulin units (TMU)/
mg] than human placental thrombomodulin (2,180 TMU/mg) and rabbit lung
thrombomodulin (1,980 TMU/mg). The UTMs prolonged thrombin-induced fi
brinogen clotting time (> 1 TMU/ml), APTT (> 5 TMU/ml), TT (> 5 TMU/ml
) and PT (> 40 TMU/ml) in a dose-dependent fashion. These effects appe
ared in the concentration range of soluble thrombomodulins present in
human plasma and urine, In the rat DIC model induced by thromboplastin
, administration of UTMs by infusion (300-3,000 TMU/kg) restored the h
ematological abnormalities derived from DIC in a dose-dependent fashio
n, These results demonstrate that UTMs exhibit potent anticoagulant an
d antithrombotic activities, and could play a physiologically importan
t role in microcirculation.